Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

Sanofi

Amunix Pharmaceuticals

Kiadis Pharma

Foundation S

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. 

Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.

Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms 

Warp Drive Bio

BioNTech

Provention Bio

Exscientia

Eden Biologics

Melinta Therapeutics

MyoKardia

Regulus Therapeutics

Fulcrum Therapeutics

Nereus Pharmaceuticals

Gyroscope Therapeutics

Icosavax

Innovent Biologics

Evotec

Blackstone Life Sciences

Enfants de Sanofi, a unique initiative in the corporate world, has provided financial and moral support to over 3,820 children of Sanofi employees around the world 🌍. Whether its educational, medical or social opportunities or aid in times of crisis, Sanofi is there to help. 

On its 30-year anniversary, learn more about the program and how it helped three families navigate the health challenges their children faced 👉 http://spkl.io/60464sXLK 

For patients like Karen Peterson, a #clinicaltrial may be their only potential care option. But often, inequities in healthcare can exclude minority communities from medical research.

For clinical trials to have an impact, study populations need to reflect the #diversity of the real world. Hear more about Karen’s journey to find a clinical trial and from Monique Adams on how we’re leveraging innovative technologies like TriNetX to design more inclusive trials.

Watch more: http://spkl.io/60444sdGs

#ConnectingTheDots

CHMP gives positive opinion to new therapy, paving the way for local approval for HCPs to now treat the T.b. rhodesiense form of #SleepingSickness, an #NTD found in Africa, with an effective, safe alternative. 

Knowing that patients are waiting for expanded treatment options fuels our ongoing innovation. Hear from Jeff Schaffnit, US Franchise Head of Rare Blood Disorders, on how #ASH23 inspires him, and helps shape our mission to break barriers in care for #RareBloodDisorders.

When he’s not jumping out of planes, Isaac channels his bold spirit to help ensure diversity in clinical trials. As a Howard University postdoctoral fellow, he's on the front lines of advancing healthcare equity by promoting inclusion and representation in medical research.

Learn more about our commitment to health equity: https://bit.ly/3Nb8W45 #AMillionConversations

NASDAQ:SNY

Sanofi

Last Close

47.69

24/04 20:00

Market Cap

125.74B

Beta: 0.41

Volume Today

1.66M

Avg: 1.77M

PE Ratio

12.09

PFCF: -

Dividend Yield

7.51%

Payout:0%

Please Sign In To Use The Chat